πŸ‡ΊπŸ‡Έ FDA
Patent

US 9682107

Postnatal stem cells and uses thereof

granted A61KA61K35/12A61K35/30

Quick answer

US patent 9682107 (Postnatal stem cells and uses thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/12, A61K35/30, A61K47/02, A61P